VECT-HORUS

VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB). Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.